¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѰǼ±ÇÐȸ Á¦9ȸ ÇǺΰúÀǻ縦 À§ÇÑ °Ç¼±Ä¡·á¼¼¹Ì³ª : 2024-04-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѰǼ±ÇÐȸ Á¦9ȸ ÇǺΰúÀǻ縦 À§ÇÑ °Ç¼±Ä¡·á¼¼¹Ì³ª : 2024-04-13
±³À°ÀÏÀÚ : 2024-04-13
±³À°Àå¼Ò : ÄÚ¿¢½º ÄÁÆÛ·±½º·ë E

±³À°ÁÖÁ¦ : "Á¦9ȸ ÇǺΰúÀǻ縦 À§ÇÑ °Ç¼±Ä¡·á¼¼¹Ì³ª"

ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѰǼ±ÇÐȸ

´ã´çÀÚ : ¹ÚÀºÁÖ ±³¼ö
¿¬¶ôó : 031-380-3767

À̸ÞÀÏ : anpark7770@hanmail.net

±³À°Á¾·ù : ÇǺΰú

Âü¼®¿¹»óÀÎ : 70¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 55ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 13ÀÏ ÄÚ¿¢½º ÄÁÆÛ·±½º·ëE 13:30~13:50 Topical agents : Why does topical treatment fail ? Á¤ÁعÎ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 13ÀÏ ÄÚ¿¢½º ÄÁÆÛ·±½º·ëE 13:50~14:10 Non biologic systemic therapy : Cyclosporin, Methotrexate ³²°æÈ­(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 04¿ù 13ÀÏ ÄÚ¿¢½º ÄÁÆÛ·±½º·ëE 14:10~14:30 Non biologic systemic therapy : Acitretin, Dimethyl fumarate ¹éÀ¯»ó(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04¿ù 13ÀÏ ÄÚ¿¢½º ÄÁÆÛ·±½º·ëE 14:30~14:50 Future oral medication ¹æöȯ(°¡Å縯ÀÇ´ë)

Åä·Ð 04¿ù 13ÀÏ ÄÚ¿¢½º ÄÁÆÛ·±½º·ëE 14:50~15:05 Q&A Âü¼®ÀÚÀü¿ø()

±³À°½Ã°£ 04¿ù 13ÀÏ ÄÚ¿¢½º ÄÁÆÛ·±½º·ëE 15:05~15:25 °Ç¼± ȯÀÚ Ä¡·á¿¡ µµ¿òÀÌ µÇ´Â ´Ù¾çÇÑ ÆÁµé ÀÌÇØ¿õ(·çÀÌÇǺΰú)

±³À°½Ã°£ 04¿ù 13ÀÏ ÄÚ¿¢½º ÄÁÆÛ·±½º·ëE 15:25~15:45 ÀÏÂ÷ÀÇ·á±â°üÀÇ °Ç¼±Ä¡·á : ±¤Ä¡·áÀÇ ¹ßÀüÀ» Áß½ÉÀ¸·Î À±ÀçÀÏ(ÀλþÀÎÇǺΰú)

Åä·Ð 04¿ù 13ÀÏ ÄÚ¿¢½º ÄÁÆÛ·±½º·ëE 15:45~15:55 Q&A Âü¼®ÀÚÀü¿ø()

±³À°½Ã°£ 04¿ù 13ÀÏ ÄÚ¿¢½º ÄÁÆÛ·±½º·ëE 16:15~16:30 Patients with cancer history Á¤±âÇå(°æÈñÀÇ´ë)

±³À°½Ã°£ 04¿ù 13ÀÏ ÄÚ¿¢½º ÄÁÆÛ·±½º·ëE 16:30~16:45 Patients with metabolic syndrome Á¤°æÀº(Ãæ³²ÀÇ´ë)

±³À°½Ã°£ 04¿ù 13ÀÏ ÄÚ¿¢½º ÄÁÆÛ·±½º·ëE 16:30~17:00 Pediatric patients ±è¼º¾Ö(°è¸íÀÇ´ë)

±³À°½Ã°£ 04¿ù 13ÀÏ ÄÚ¿¢½º ÄÁÆÛ·±½º·ëE 17:00~17:15 Women of childbearing potential ±èÁ¤Àº(ÇѾçÀÇ´ë)

Åä·Ð 04¿ù 13ÀÏ ÄÚ¿¢½º ÄÁÆÛ·±½º·ëE 17:15~17:30 Q&A Âü¼®ÀÚÀü¿ø()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѰǼ±ÇÐȸ Á¦9ȸ ÇǺΰúÀǻ縦 À§ÇÑ °Ç¼±Ä¡·á¼¼¹Ì³ª : 2024-04-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ¸Þ¸®³îº´¿ø °³¿ø 74Áֳ⠱â³ä À̺ñÀÎÈÄ°ú ¿¬¼ö°­Á : 2024-04-13
´ÙÀ½±Û ´ëÇѾȽŰæÀÇÇÐȸ Áö¿ª¼øȸ ±³À°°­Á : 2024-04-13
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20499 ¼­¿ï Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥ : 2024-05-11 0 60 2024-04-29
20498 ºÎ»ê ¸¸¼ºÆó¼â °ü»óµ¿¸Æ ÁßÀç½Ã¼ú¿¬±¸È¸ The 23rd K-CTO(Korean Chronic Total Occlusion Club) Live Demonstration : 2024-05-11 0 40 2024-04-29
20497 ¼­¿ï ´ëÇÑÀü¸³¼±ÇÐȸ The 3rd Korean Prostate Society Prostate Cancer Working Group Symposium : 2024-05-11 0 43 2024-04-29
20496 ¼­¿ï 2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-11 0 24 2024-04-29
20495 ¼­¿ï Á¦77Â÷ ´ëÇÑû°¢ÇÐȸ Çмú´ëȸ : 2024-05-11 0 52 2024-04-29
20494 ÀÎõ Á¦9ȸ °¡Ãµ´ë ±æº´¿ø ½Å°æ¿Ü°ú ¾÷µ¥ÀÌÆ® ½ÉÆ÷Áö¿ò (G-NeUS) : 2024-05-11 0 50 2024-04-29
20493 ´ëÀü 2024³â ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ Ãá°èÇмú´ëȸ & Basic Training Course : 2024-05-11 0 40 2024-04-29
20492 ±¤ÁÖ 2024³â ´ëÇѼҾƺñ´¢ÀÇÇÐȸ Á¦37Â÷ Çмú´ëȸDAY2 : 2024-05-11 0 45 2024-04-29
20491 ¼­¿ï Á¦50ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-05-11 0 39 2024-04-29
20490 ¼­¿ï ÇѾç´ëÇб³º´¿ø Á¤Çü¿Ü°ú ⸳ 52Áֳ⠱â³äÇмú´ëȸ : 2024-05-11 0 85 2024-04-29
20489 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¼ºÇü¿Ü°úÇб³½Ç â¸³ 50Áֳ⠱â³ä Çмú´ëȸ : 2024-05-11 0 44 2024-04-29
20488 °æ±â ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2024 Spring Semi-Annual Meeting (2ÀÏÂ÷) : 2024-05-11 0 51 2024-04-29
20487 °­¿ø 2024³â ´ëÇѺ´¸®ÇÐȸ º½Çмú´ëȸ(2ÀÏÂ÷) : 2024-05-10 0 48 2024-04-29
20486 ¼­¿ï 2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-10 0 69 2024-04-29
20485 ¼­¿ï ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ 2024 Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2024-05-10 0 40 2024-04-29
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷